Emtricitabine triphosphate in dried blood spots predicts future viremia in persons with HIV and identifies mismatch with self-reported adherence

Emtricitabine triphosphate in dried blood spots predicts future viremia in persons with HIV and identifies mismatch with self-reported adherence

This study established that emtricitabine triphosphate (FTC-TP) in dried blood spots, a measure of short-term adherence, is predictive of future viremia, in particular in persons living with HIV who report 100% adherence in the preceding 3 days.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS (London) 2021-10, Vol.35 (12), p.1949-1956
Hauptverfasser: Morrow, Mary, MaWhinney, Samantha, Coyle, Ryan P., Coleman, Stacey S., Zheng, Jia-Hua, Ellison, Lucas, Bushman, Lane R., Kiser, Jennifer J., Anderson, Peter L., Castillo-Mancilla, Jose R.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This study established that emtricitabine triphosphate (FTC-TP) in dried blood spots, a measure of short-term adherence, is predictive of future viremia, in particular in persons living with HIV who report 100% adherence in the preceding 3 days.
ISSN:0269-9370
1473-5571
DOI:10.1097/QAD.0000000000002981